Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
20 Dec 2015 ESMO Asia 2015 News: RADIANT-4 Supports Everolimus in Neuroendocrine Tumour Patients Gastrointestinal cancers
20 Dec 2015 ESMO Asia 2015 News: Cancer-associated Venous Thromboembolism Incidence Underestimated Palliative and supportive care
19 Dec 2015 ESMO Asia 2015 News: Durvalumab, Tremelimumab Duo Promising in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
18 Dec 2015 ESMO Asia 2015 News: Endocrine Therapy in Premenopausal Women: Selecting Patients, Treatments and Durations Breast cancer - Anticancer agents & Biologic therapy
16 Dec 2015 No Benefit From Adjuvant Chemotherapy in High Risk Premenopausal Luminal A Breast Cancer Patients Breast cancer - Pathology/Molecular biology - Anticancer agents & Biologic therapy
16 Dec 2015 The Impact of Adjuvant Denosumab on Disease-free Survival in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Breast cancer - Palliative and supportive care - Anticancer agents & Biologic therapy
15 Dec 2015 FDA Approves Uridine Triacetate for the Emergency Treatment of Patients Who Receive an Overdose of Fluorouracil or Capecitabine Palliative and supportive care
14 Dec 2015 FDA Approves Alectinib for the Treatment of Advanced ALK-positive NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 Dec 2015 FDA Allows Marketing of Cooling Cap to Reduce Alopecia During Chemotherapy Palliative and supportive care
09 Dec 2015 Midostaurin Prolongs Survival in Newly Diagnosed Acute Myeloid Leukaemia Patients With FLT3 Mutations Haematologic malignancies - Anticancer agents & Biologic therapy
03 Dec 2015 FDA Approves Elotuzumab for the Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Dec 2015 Lung Adenocarcinoma With HER2 Mutations Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Dec 2015 NHS England and NICE Have Begun a Consultation on a New Cancer Drugs Fund Bioethics, legal and economic issues
30 Nov 2015 FDA Approves Nivolumab as a Single Agent for Previously Untreated BRAF Wild-Type Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
27 Nov 2015 FDA Approves Necitumumab to Treat Advanced Squamous NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy